Figure 5.
A. Anchorage-independent growth and colony formation in MDA-MB-231 breast cancer cells is impaired by FLLL31 and FLLL32. B. The invasive capacity of MDA-MB-231 breast cancer cells is reduced to a greater extent by FLLL31 and FLLL32 than curcumin. C. FLLL31 or D. FLLL32 exhibits synergy with doxorubicin (Doxo) in growth suppression of MDA-MB-231 breast cancer cells.